Cargando…

Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma

PURPOSE: Hypoxia is a leading hallmark of tumors, which is associated with carcinogenicity and dismal patient outcome. In this project, we tended to detect the prognostic value of hypoxic lncRNA and further generate a hypoxic lncRNA-based model in head and neck squamous cell carcinoma (HNSCC). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Cuifang, Zheng, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791745/ https://www.ncbi.nlm.nih.gov/pubmed/35096063 http://dx.doi.org/10.1155/2022/6775496

Ejemplares similares

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
por: Xiang, Junwei, et al.
Publicado: (2022)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma
por: Mao, Rui, et al.
Publicado: (2020)

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression
por: Tang, Jianmin, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Wu, Congxiao, et al.
Publicado: (2022)

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma
por: Yang, Bowen, et al.
Publicado: (2019)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma
por: He, Xiaohua, et al.
Publicado: (2022)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
por: Liu, Xiajing, et al.
Publicado: (2022)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
por: Kopczyńska, Magda, et al.
Publicado: (2020)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates
por: de Lena, Pelayo G., et al.
Publicado: (2017)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature
por: Jing, Lijun, et al.
Publicado: (2022)

Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma
por: Yu, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h80f6n2ddg2orqhnogn3bojjo9